Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
73 Cards in this Set
- Front
- Back
- 3rd side (hint)
(2) diuretics used for HTN
what do both lower as an AE? |
Thiazides
Loops both lower K+ |
|
|
Vasodilator used for severe HTN and CHF
AE? |
Hydralazine
AE: SLE-like effects |
|
|
Vasodilator used for emergency HTN situations
AE? |
Nitroprusside
AE: converts to cyanide |
|
|
Anti-HTN, anti-anginal and anti-arrhythmic class that works by reducing heart contractility
(2) AE |
Calcium channel blockers
AE: Cardiac depression; Edema |
|
|
which of the calcium channel blockers most specific for:
Vascular Smooth Muscle |
Nifedipine
|
|
|
which of the calcium channel blockers most specific for:
Heart muscle |
Verapamil
|
|
|
Drug for angina that also is effective against pulmonary edema
|
Nitroglycerine
|
|
|
what are the (5)* determinants of myocardial oxygen consumption?
|
BEECH:
BP, Ejection time, EDV, Contractility, HR |
BEECH
|
|
Drug used for CHF and A-fib can cause arrthymias
what are the ECG changes? (3) |
Digoxin
ECG: Inc PR Dec QT T-wave inversion |
|
|
MOA of digoxin
(2) AE? |
Inhibit Na/K pump to indirectly inhibit Na/Ca antiport, causing Ca increase inside cell
AE: Yellow vision; Arrhythmias |
|
|
(4)* class IA antiarrhythmics
|
Queen Amy Proclaims Diso's PYRAMID:
Quinidine, Amiodarone, Procainamide, Disopyramide |
Queen Amy Proclaims Diso's PYRAMID
|
|
MOA of class IA Na-channel blockers
what type of arrhythmias is it good for? |
Inc action potential duration by Inc QRS (QT interval)
Use: Ventricular Arrhythmia |
|
|
how do the Na-channel blockers affect HR, CO, BP and SV?
|
Dec HR -> Dec CO -> Dec BP -> Inc SV
(more time to fill) |
|
|
AE for Quinidine
|
Cinchonism:
HA, Tinnitus, thrombocytopenia, Torsades de Pointes |
|
|
why are Procainamide and Disopyamide successful at slowing the QT interval?
|
both are Amides, which are metabolized in the liver giving NH4 that can be converted to GLU -> GABA
|
|
|
AE for Procainamide
|
SLE-like effects
|
|
|
DOC for V-Tach
|
Lidocaine
(b/c it affects ischemic tissues and works quickly; IV only) |
|
|
what is the class and drug that is the last resort (V-fib) as a
Na-channel blocker? when is it contra-indicated? |
Class IC: Flecainide
CI: post-MI (leads to heart stopping) |
|
|
Na-channel blocker class/drug that decreases Action Potential time
|
Class IB: Lidocaine
|
|
|
(3) drugs that can block both Na and Ca channels
what Dx are they good for? |
Procainamide,
Phenytoin, Quinidine use: Wolf Parkinson White |
|
|
Class II antiarrhythmics class and MOA
|
Beta-blockers
MOA: Dec cAMP and Ca currents -> Dec slope of phase 4 and Inc PR interval |
|
|
(3) AE of Beta-blockers
|
blocking betas make me SICk:
Sedation, Impotence, CV effects (bradycardia, CHF) |
blocking betas make me SICk
|
|
B-blocker:
Longest acting |
Propranolol
|
|
|
B-blocker:
Shortest acting |
Esmolol
|
|
|
B-blocker:
also blocks Alpha-receptors (for Pheos and HTN crisis) (2) |
Labetalol
Carvedilol |
|
|
B-blocker:
for Miosis |
Timolol
|
|
|
B-blocker:
also blocks K+ channels |
Sotalol
|
|
|
B-blocker:
good for patient w/ DM, asthmatics, MI and elderly |
Atenolol
|
|
|
(3)* drugs in Class III anti-arrhythmics
|
BiAS to K-channel blockers:
Bretylium, Amiodarone, Sotalol |
BiAS to K-channel blockers
|
|
MOA of K-channel blockers
|
Inc AP by Inc QT interval
|
|
|
AE of Amiodarone
(4) |
Amy aught to run PFTs, LFTs and TFTs or you'll be BLUE:
Pulmonary fibrosis, Hepatotoxicity, Hyper/Hypothyroidism (contains iodine), turns skin Blue |
Amy aught to run PFTs, LFTs and TFTs or you'll be BLUE
|
|
Class of choice for Atrial arrhythmias
MOA |
Ca-Channel blockers;
For AV nodal cells, Inc ST segment and Inc PR interval |
|
|
DOC for Digitalis-induced arrthymias
|
Phenytoin
|
|
|
drug that inhibits VLDL production, Dec TG and Dec HDL breakdown
AE? |
Niacin
AE: Flushing |
|
|
class that increases the production of lipoprotein lipase to
Inc breakdown of TG (2) AE? |
Fibrates
"-FIBR-" (Gemfibrozil, Fenofibrate) AE: GI upset, gall stones |
|
|
contraindication of Bile Acid Sequestrants?
|
High TG levels...BAS Increases TG
|
|
|
DOC in AV nodal arrhythmias
|
Adenosine
|
|
|
Antiarrhythmic that depresses ectopic pacemakers
(esp digoxin toxicity) |
Potassium
|
|
|
(3) First generation H1 blockers
|
Diphenhydramine (Benadryl),
Chlorpheniramine (Chlor-trimeton), Promethazine (Phenergan) |
First gen H1 for:
resp: "-amine" GI: "-azine" |
|
Clinical uses (3) and AE (3) of First generation H1 blockers
|
Uses:
Motion sickness Allergy (hives, itching, nasal), Sleep aid AE: Sedation, Antimuscarinic, Anti-alpha-adrenergic |
|
|
(3) Second generation H1 blockers
Use? |
Loratadine (Claritin),
Fexofenadine (Allegra), Centirazine (Zyrtec) Use: Non-drowsy Allergic rhinitis, Hay fever |
second gen H2 for allergy:
"-adine" or "-azine" |
|
Name and MOA of a Nasal Decongestant
|
Pseudoepherine (Sudafed)
Alpha-agonist leading to vasoconstriction |
|
|
(2) Cough suppressants
|
Codeine,
Dextromethophan (DM) |
|
|
Name and MOA of expectorant
|
Guaifenesin
(Robitussin) Inc. respiratory secretions and viscosity |
|
|
Long acting B2-agonist for Asthma Prophylaxis
|
Salmeterol
|
|
|
Methylxanthine used for Severe asthma
MOA? (2) AE? |
Theophylline
Bronchodilator by Inh Phosphodiesterase and Dec cAMP hydrolysis AE: Cardiotoxicity; Neurotoxicity |
|
|
Drug and MOA of Mast Cell Stabilizers
Use? |
Cromolyn
causes Mast cells not to release histamine use: Only for Prophylaxis |
|
|
what is the most potent anti-inflammatory agent that is effective for mild, moderate and severe asthma
(first line for chronic asthma)? MOA? |
Glucocorticosteroids
Inh NF-kB transcription factor that induces TNF-alpha, inhibiting formation of PGE and LTE |
|
|
(2) Adverse effects of Glucocorticoids?
|
Oral candidiasis,
bone demineralization |
|
|
Leukotriene effect modulator that inhibits lipoxygenase and leukotriene formation
AE? |
Zileuton
AE: Hepatotoxicity |
|
|
(2) Leukotriene effect Modulator that binds the leukotriene receptors
Use? |
Zafirlukast,
Montelukast Use: Prophylaxis; mild/moderate asthma |
|
|
Muscarinic antagonist that prevents bronchoconstriction
|
Ipratropium
|
|
|
non-specific Beta-agonist that relaxes bronchial smooth muscle
AE? |
Isoproterenol
AE: tachycardia |
|
|
What asthma agents deal with an early response (bronchoconstriction)?
(4) |
My BLT:
Muscarinic antagonist, Beta-agonist, Leukotriene antagonist, Theophylline |
My BLT
|
|
what asthma agents deal w/ mast cells releasing mediators?
(2) |
Cromolyn,
Steroids |
|
|
Ganglionic blocker (rarely used) for the rapid reduction of HTN
|
Trimethaphan
|
|
|
only drug that reduces morbidity and mortality in heart failure
|
Spironoloactone
|
|
|
drug given IV for severe acute heart failure
|
Dobutamine
|
|
|
what anti-HTN drug may ilicit a positive Coombs test and hemolytic anemia?
|
Methyldopa
|
|
|
DOC for variant angina
|
Nifedipine
|
|
|
what drug interaction w/ Digoxin increases its toxicity?
|
Thiazides
(Dec K+ -> Inc Dig toxicity) |
|
|
Anti-anginal Tx that has AE of severe constipation
|
Verapamil
|
|
|
(2) AE of Adenosine
|
Burning sensation in chest,
SOB |
|
|
(2) AE of Dobutamine
|
Inc HR and BP
|
|
|
HTN medication that has AE of "Loss of taste"
|
ACEi
|
|
|
patient treated w/ anti-arrhythmic that causes recurrent attacks of feeling faint and experiencing episodes of loss of consciousness. what drug?
|
Quinidine
|
|
|
Cardiac AP drug:
affects Phase 4 (3) |
Digoxin,
Verapamil (Ca-channel blockers), Lidocaine |
|
|
Cardiac AP drug:
affects Phase 0 to slow conduction and prolong repolarization |
IA drugs
(All class I slow conduction, but only IA prolongs repolarization) |
|
|
Cardiac AP drug:
affects Phase 0 but causes no change in repolarization |
Class IC - Flecainide
|
|
|
Cardiac AP drug:
blocks Na, Ca and K channels |
Amiodarone
|
|
|
Drug that lowers HTN by inhibiting Peptidyl Dipeptidase
|
ACEi
(at biochemical level) |
|
|
drug class for CHF that decreases Preload and BV
|
ACEi
|
|
|
only Drug class that increases the survival rate in CHF
|
ACEi
|
|